Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017–2018 season
- 1 June 2019
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 37 (29), 3856-3865
- https://doi.org/10.1016/j.vaccine.2019.05.041
Abstract
No abstract availableFunding Information
- U.S. Food and Drug Administration
- Centers for Medicare & Medicaid Services (244-18-1067S)
This publication has 39 references indexed in Scilit:
- Surveillance for Guillain-Barré syndrome after 2015–2016 and 2016–2017 influenza vaccination of Medicare beneficiariesVaccine, 2019
- Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyThe Lancet, 2016
- Guillain-Barré syndromeThe Lancet, 2016
- Lack of Association of Guillain-Barre Syndrome With VaccinationsClinical Infectious Diseases, 2013
- Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2011
- Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety dataVaccine, 2011
- Guillain-Barré syndrome after exposure to influenza virusThe Lancet Infectious Diseases, 2010
- AN EPIDEMIOLOGIC AND CLINICAL EVALUATION OF GUILLAIN-BARRÉ SYNDROME REPORTED IN ASSOCIATION WITH THE ADMINISTRATION OF SWINE INFLUENZA VACCINESAmerican Journal of Epidemiology, 1984
- Guillain-Barré Syndrome: The Swine Influenza Virus Vaccine Incident in the United States of America, 1976–77: Preliminary CommunicationJournal of the Royal Society of Medicine, 1979
- GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771American Journal of Epidemiology, 1979